Next Article in Journal
Decreasing Postoperative Pulmonary Complication Following Laparoscopic Surgery in Elderly Individuals with Colorectal Cancer: A Competing Risk Analysis in a Propensity Score–Weighted Cohort Study
Next Article in Special Issue
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
Previous Article in Journal
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
Previous Article in Special Issue
The Omentum in Obesity-Associated Cancer: A Hindrance to Effective Natural Killer Cell Migration towards Tumour Which Can Be Overcome by CX3CR1 Antagonism
Review

Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma

1
Laboratory of Nervous System Diseases and Therapy, GIGA Neuroscience, GIGA Institute, University of Liège, 4000 Liege, Belgium
2
Immuno-Pharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, 1445 Strassen, Luxembourg
3
Faculty of Science, Technology and Medicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg
4
Neurology Department, University Hospital, University of Liège, 4000 Liege, Belgium
5
Neurosurgery Department, University Hospital, University of Liège, 4000 Liege, Belgium
6
Tumor Immunotherapy and Microenvironment, Department of Oncology, Luxembourg Institute of Health, 1445 Strassen, Luxembourg
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Bernhard Moser
Cancers 2022, 14(1), 130; https://doi.org/10.3390/cancers14010130
Received: 23 November 2021 / Revised: 23 December 2021 / Accepted: 24 December 2021 / Published: 28 December 2021
(This article belongs to the Special Issue Emerging Roles of Chemokines in Cancer Immunotherapy)
Chemokines and their receptors have been pointed out as key actors in a variety of human cancers, playing pivotal roles in multiples processes and pathways. The present study aims at deciphering the functions of several chemokine receptors in gliomas, starting from publicly available patient-derived transcriptomic data with support from the current literature in the field, and sheds light on the clinical relevance of chemokine receptors in targeted therapeutic approaches for glioma patients.
Gliomas are severe brain malignancies, with glioblastoma (GBM) being the most aggressive one. Despite continuous efforts for improvement of existing therapies, overall survival remains poor. Over the last years, the implication of chemokines and their receptors in GBM development and progression has become more evident. Recently, large amounts of clinical data have been made available, prompting us to investigate chemokine receptors in GBM from a still-unexplored patient-oriented perspective. This study aims to highlight and discuss the involvement of chemokine receptors—CCR1, CCR5, CCR6, CCR10, CX3CR1, CXCR2, CXCR4, ACKR1, ACKR2, and ACKR3—most abundantly expressed in glioma patients based on the analysis of publicly available clinical datasets. Given the strong intratumoral heterogeneity characterizing gliomas and especially GBM, receptor expression was investigated by glioma molecular groups, by brain region distribution, emphasizing tissue-specific receptor functions, and by cell type enrichment. Our study constitutes a clinically relevant and patient-oriented guide that recapitulates the expression profile and the complex roles of chemokine receptors within the highly diversified glioma landscape. Additionally, it strengthens the importance of patient-derived material for development and precise amelioration of chemokine receptor-targeting therapies. View Full-Text
Keywords: glioma; chemokine receptor; patient-derived transcriptomic data; malignant processes; tumor microenvironment glioma; chemokine receptor; patient-derived transcriptomic data; malignant processes; tumor microenvironment
Show Figures

Figure 1

MDPI and ACS Style

Isci, D.; D’Uonnolo, G.; Wantz, M.; Rogister, B.; Lombard, A.; Chevigné, A.; Szpakowska, M.; Neirinckx, V. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers 2022, 14, 130. https://doi.org/10.3390/cancers14010130

AMA Style

Isci D, D’Uonnolo G, Wantz M, Rogister B, Lombard A, Chevigné A, Szpakowska M, Neirinckx V. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers. 2022; 14(1):130. https://doi.org/10.3390/cancers14010130

Chicago/Turabian Style

Isci, Damla, Giulia D’Uonnolo, May Wantz, Bernard Rogister, Arnaud Lombard, Andy Chevigné, Martyna Szpakowska, and Virginie Neirinckx. 2022. "Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma" Cancers 14, no. 1: 130. https://doi.org/10.3390/cancers14010130

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop